1. THU0677 Outcome measurement instruments for safety in rheumatology: a scoping review of available instruments to inform the omeract safety working group. (15th June 2017) Authors: Klokker, L; Woodworth, T; Furst, DE; Tugwell, P; Devoe, D; Williamson, P; Terwee, CB; Suarez-Almazor, ME; Strand, V; Leong, AL; Goel, N; Boers, M; Brooks, PM; Simon, LS; Christensen, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0224 Celecoxib decreased dyspepsia in osteoarthritis and rheumatoid arthritis patients: severity of dyspepsia assessment (soda) results from the ?celecoxib long-term arthritis safety study? (class 2), a randomised trial comparing celecoxib and diclofenac. (1st June 2001) Authors: Goldstein, JL; Pena, BM; Dedhiya, D; Simon, LS Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The regulatory perspective. Issue 2 (October 2014) Authors: Simon, LS Journal: Journal of the peripheral nervous system Issue: Volume 19:Issue 2(2014) Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗